ライフサイエンスコーパス: anti-IgG

1 between the immobilized IgG with a suitable anti-IgG.

2 and brlf1 mRNAs can be detected 1.5 h after anti-IgG.

3 e edge sites for subsequent amide linkage to anti-IgG.

4 phorylated following stimulation with either anti-IgG Abs or pervanadate in the murine B cell lymphom

5 Anti-IgG activates a complex signal transduction pathway

6 fluorophore-labeled anti-mouse IgG antibody (anti-IgG-Alexa Fluor 647) is used.

7 of Akata cells reactivated from latency with anti-IgG and a lymphoblastoid cell line (LCL) reactivate

8 LCgamma in GC B cells after stimulation with anti-IgG and anti-CD40.

9 The anti-IgG and anti-HSA are separately immobilized on two

10 r system, we demonstrated 100% detachment of anti-IgG and IgG bound beads (which is on the same order

11 both, secondary and primary nanogold probes (anti-IgG and IgG coupled to AuNP, on double and single-a

12 , and the second was the interaction between anti-IgG and IgG.

13 Phorbol esters, anti-immunoglobulin G (anti-IgG), and, surprisingly, 5-aza-2'-deoxycytidine req

14 , which blocked subsequent responses to OVA, anti-IgG, and anti-kappa, but also competed for binding

15 vation of EBV in Akata cells, in response to anti-IgG, and in Raji cells, in response to tetradecanoy

16 own to be expressed by 1 h after addition of anti-IgG, and their expression preceded that of bzlf1 an

17 Serum samples were tested for anti-IgG antibodies to CMV and HSV from 400 subjects (me

18 he nonspecific interaction between AuNPs and anti-IgG antibodies to realize sensitive detection of Ig

19 ncept, we designed a mass-based sensor where anti-IgG antibodies were coated on a quartz crystal micr

20 Capture anti-IgG antibodies were then coupled through peptide bo

21 n of horseradish peroxidase (HRP)-conjugated anti-IgG antibodies.

22 rified cell lysates and culture medium using anti-IgG antibodies.

23 Anti-IgG antibody conjugated FITC-doped silica nanoparti

24 of a B lymphoma cell line, A20, with intact anti-IgG antibody induced a direct, SH2-mediated associa

25 ped AuNPs were applied to bind with the free anti-IgG antibody molecules.

26 Retinal immunocytochemistry with anti-IgG antibody showed IgG penetration throughout the

27 Specimens depleted of IgG with anti-IgG antibody were reassayed to measure anti-E prote

28 zacytidine), B cell receptor engagement with anti-IgG antibody, hydrogen peroxide, and the proteosome

29 n the surface were conjugated to a secondary anti-IgG antibody.

30 odel sandwich assay system with biotinylated anti-IgG as the capture antibody, rabbit IgG as the anti

31 acrylate copolymer, an antibody/antigen (IgG/anti-IgG) assay was carried out to assess the performanc

32 In contrast, anti-IgG attaches randomly onto the terrace regions of A

33 Thus, using anti-IgG-AuNP, the detectability could be improved by a

34 d-phase binding assay that utilizes magnetic anti-IgG beads to capture CAP18(106-138)-IgG (and bound

35 hieved via the Fc-specific FITC@SiO(2)-NH(2)-anti-IgG binding to the captured anti-p53aAbs.

36 ulin G (IgG) covalent immobilization, an IgG/anti-IgG bioassay was implemented along the grating regi

37 ected before 2 h in Akata cells treated with anti-IgG, but both long- and short-duration stimuli requ

38 s required up to 1.25 h after application of anti-IgG; bzlf1 and brlf1 mRNAs can be detected 1.5 h af

39 o anti-human and anti-rabbit immunoglobulin (anti-IgG) concentrations less than 100 nM using only 10

40 mobilized, mAbs are probed using a secondary anti-IgG conjugated with horseradish peroxidase.

41 te cytokine responses, which upon additional anti-IgG crosslinking were significantly boosted.

42 ivity was further enhanced using a secondary anti-IgG detection antibodies to give a limit of detecti

43 Bromodeoxyuridine birthdating and anti-IgG double-labeling studies showed that most of the

44 pecific binding and have been able to detect anti-IgG even in the presence of 100-fold larger concent

45 In contrast, stimulation of A20 cells with anti-IgG F(ab')2 resulted in little increase in the asso

46 fluorescein-5'-isothiocyanate (FITC)-labeled anti-IgG F(ab) antibodies to the recycling endosomes in

47 ) using nanomagnetic beads capture probe and anti-IgG functionalized-fluorescence nanoparticles as th

48 ity constants reported in the literature for anti-IgG/IgG binding pairs and provides intrinsic detect

49 bioaffinity binding between IgG and specific anti-IgG in real-time.

50 The BSA concentration and the HRP-anti-IgG incubation had very limited influence.

51 n of the cells with either F(ab')2 or intact anti-IgG induced very similar changes in levels of tyros

52 erforming the same model assay after spiking anti-IgG into human serum.

53 After rinsing, peroxidase-conjugated anti-IgG is drawn through the membrane followed by rinsi

54 ERS), which utilizes a Fe3O4@Ag@streptavidin@anti-IgG nanocomposite with strong magnetic properties a

55 selectivity was achieved by the presence of anti-IgG on the surface of silver nanoparticles coupled

56 ion of a coating antibody (Ab), a polyclonal anti-IgG, onto a treated PDMS surface.

57 seen with V1-69 encoded antibodies that have anti-IgG or rheumatoid factor activity.

58 aling of protein kinase A was blocked by CM, anti-IgG, or by specific inhibitors of the beta-adrenerg

59 ry antigen bound to microtitration wells and anti-IgG- plus anti-IgM-coated indicator erythrocytes as

60 over the location of anti-immunoglobulin G (anti-IgG) proteins bound to Au nanoplates formed on glas

61 ure antibody, rabbit IgG as the antigen, and anti-IgG-R-phycoerythrin as the reporter antibody, we de

62 (LSPR) response upon binding than those with anti-IgG randomly attached to terrace regions.

63 t (but neither alone) or by a combination of anti-IgG receptor and anti-IgE antibodies.

64 e alkali hydrolysis of the FITC@SiO(2)-NH(2)-anti-IgG released FITC molecules, leading to an amplifie

65 (r approximately 0.85; P < 0.00001) with the anti-IgG results but showed no advantage over measuring

66 g of anti-MOG.MOG complexes with a secondary anti-IgG results in the lipid raft-dependent phosphoryla

67 Polyclonal anti-immunoglobulin G (anti-IgG) secondary antibodies are essential tools for m

68 Importantly, Au nanostructures with anti-IgG selectively bound to the edge sites exhibit sig

69 Anti- IgG seroconversion occurred in eight -seronegative

70 in survival was found between the different anti- IgG serogroups (D-R-, D-R+, D+R-, or D+R+).

71 xylated IL (IL-COOH), was used to immobilize anti-IgG to create an affinity biosensor.

72 These genes were activated by anti-IgG treatment of Akata cells with and without the E

73 c cycle activation occurs very rapidly after anti-IgG treatment, de novo protein synthesis is also re

74 ation procedure based on stripping off bound anti-IgG treatment.

75 tion of Cy5 labeled IgG and Alexa633 labeled anti-IgG using a single laser source (636 nm excitation)

76 horylation of p40/42 in A20 cells induced by anti-IgG was rapid and transient, peaking at 2 min after

77 ntrol zone, antibody of S. typhi O901 and an anti-IgG were dotted on the nitrocellulose membrane, res

78 gand binding pairs (streptavidin/biotin; IgG/anti-IgG) were quantified.

79 died the interaction of fluorescently tagged anti-IgG with surface immobilized IgG controlled by elec